Bladder Cancer Trial, Recruiting (NCT07165236)

Bladder Cancer Trial, Recruiting NCT07165236 Sponsor: Osijek University Hospital Condition: Bladder Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07165236 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bladder Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults between 18 and 80 years of age
People scheduled for a planned (non-emergency) surgical procedure to treat bladder cancer (a procedure called TUR, which removes tumour tissue from the bladder)
People who are able to communicate
People who are able to sign a consent form and complete questionnaires

Who may not be able to join:

People under 18 years of age
People over 80 years of age
People who are unable to communicate
People who are unable to understand the research consent form
People who are unable to write
People requiring emergency surgery
People who have a known allergic reaction or sensitivity to any of the medications used in the study
People who are in a state of shock (such as from severe infection or significant blood loss), or who have a neurodevelopmental disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Slavica Kvolik, MD, PhD, KBC Osijek

Phone: +385 511 502

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07165236

Sponsor: Osijek University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Bladder Cancer

Trial contact: +385 511 502

More information: https://clinicaltrials.gov/study/NCT07165236

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults between 18 and 80 years of age
People scheduled for a planned (non-emergency) surgical procedure to treat bladder cancer (a procedure called TUR, which removes tumour tissue from the bladder)
People who are able to communicate
People who are able to sign a consent form and complete questionnaires

Who may not be able to join:

People under 18 years of age
People over 80 years of age
People who are unable to communicate
People who are unable to understand the research consent form
People who are unable to write
People requiring emergency surgery
People who have a known allergic reaction or sensitivity to any of the medications used in the study
People who are in a state of shock (such as from severe infection or significant blood loss), or who have a neurodevelopmental disorder

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Osijek University Hospital

Registry

ClinicalTrials.gov

Start date

28 November 2024

Est. completion

1 October 2026

Where this trial is recruiting

🇭🇷 Croatia

Primary endpoints

to examine whether the current cognitive state as measured by the Mini-Mental State Examination (MMSE) changes after the patient is exposed to surgery and general anesthesia.; To examine whether the current cognitive state, as measured using the Montreal Cognitive Assessment (MoCA), changes after the patient is exposed to surgery and general anesthesia.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov